| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |